Funder
National Cancer Institute
Reference36 articles.
1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021
2. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005
3. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000
4. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience;Dash;Cancer,2008
5. Cancer Stat Facts: Bladder Cancer. NIH NCI: surveillance, epidemiology, and end results program. https://seer.cancer.gov/statfacts/html/urinb.html. Published 2019. Accessed August 11, 2021.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献